Common Contracts

Clinical Trial Agreement – International Protocol No. APL-GA-305

Trial Agreement • December 10th, 2021

• Contract Type
  Trial Agreement
• Filed
  December 10th, 2021

CLINICAL TRIAL AGREEMENT SMLOUVA O KLINICKÉM HODNOCENÍ THIS CLINICAL TRIAL AGREEMENT(together with Exhibit A, the “Agreement”) is made as of last date of signature and effective as of the date of publication in the Register of Contracts, (the “Effective Date”) by and between Apellis Pharmaceuticals, Inc., a Delaware corporation with an office at 100 5th Avenue, Waltham MA 02451 (“Sponsor” or “Apellis”) and Labcorp Drug Development Inc., 206 Carnegie Center, Princeton, NJ 08540, USA, represented by, and its affiliates (hereinafter referred to as “Labcorp”)and Fakultní nemocnice Ostrava17. listopadu 1790/5, 708 52 Ostrava-Poruba, Czech RepublicID: 00843989Tax ID: CZ00843989Charter of the Ministry of Health of the Czech Republic of 25 November 1990 File no. OP-054- 25/11/90Person authorized to act and sign in matters of this contract: doc. and doc. MUDr. Petr Vávra, Ph.D., Deputy Director for Science, Research and Teaching (“Institution”)and MUDr. Jan Němčanský, Ph.D., with place of busin